Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players├óÔéČÔäó financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cardiac Biomarkers Companies

Cardiac biomarkers play a crucial role in diagnosing and managing cardiovascular diseases by providing essential information about the heart's health. These biomarkers are measurable substances in the blood that indicate the presence or severity of cardiovascular conditions.

Cardiac Biomarkers Key Companies


Latest Cardiac Biomarkers Companies Update:

Abbott (US) Received FDA approval for its ElevateÔäó assay, a new generation high-sensitivity troponin test offering improved accuracy for early detection of heart attacks.

Roche (Switzerland) Collaborated with Mayo Clinic to develop a novel blood test based on a combination of cardiac biomarkers and AI algorithms for diagnosing heart failure with improved accuracy.

Siemens Healthineers (Germany) Launched the Atellica® CHD 99 test, a multi-biomarker panel for comprehensive assessment of cardiovascular disease risk, including detection of acute and chronic myocardial injuries.

Quidel Corporation (US) Developed the Sofia® BNP test, a rapid point-of-care test for measuring B-type natriuretic peptide, a key biomarker for heart failure diagnosis and management.

Alnylam Pharmaceuticals (US) Focused on developing RNA interference (RNAi) therapeutics targeting cardiac biomarkers for early intervention and prevention of cardiovascular diseases.

List of Cardiac Biomarkers Key companies in the market

  • Novartis AG (Switzerland)

  • Quidel Corporation (US)

  • ACS Biomarker B.V (Netherlands)

  • Randox Laboratories Ltd (UK)

  • Trivitron Healthcare (India)

  • Hoffman La Roche Ltd (Switzerland)

  • Johnson & Johnson Services Inc. (US)

  • Abbott Laboratories (US)

  • Siemens (Germany)

  • Thermo Fisher Scientific Inc (US)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.